Search

1. ACNS0332: Efficacy of Carboplatin Administered Concomitantly With Radiation and Isotretinoin as a Pro-Apoptotic Agent in Other Than Average Risk Medulloblastoma/PNET Patients: (Uncategorised); ... your treatment team. Study Number ACNS0332 Study Title Efficacy of Carboplatin Administered Concomitantly With Radiation and Isotretinoin as a Pro-Apoptotic Agent in Other Than Average Risk Medulloblastoma/PNET ...; Created on 17 August 2015
2. ACNS1422: A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients: (Family Protocol Summaries ); ... any questions that you may have with your health care team. Study Number ACNS1422 Official Title A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients ...; Created on 12 August 2015
3. ACNS1221 - A Phase II Study for the Treatment of Non-Metastatic Nodular Desmoplastic Medulloblastoma in Children Less Than 4 Years of Age: (Family Protocol Summaries ); ... of Non-Metastatic Nodular Desmoplastic Medulloblastoma in Children Less Than 4 Years of Age Study Opening Date ACNS 1221 opened on 12/24/2013and closed on 7/27/2016. Study closure was based on review ...; Created on 24 July 2015
4. ACNS0821: Temozolomide with Irinotecan versus Temozolomide, Irinotecan plus Bevacizumab for Recurrent/Refractory Medulloblastoma/CNS PNET of Childhood: (Family Protocol Summaries ); ... Irinotecan versus Temozolomide, Irinotecan plus Bevacizumab for Recurrent/Refractory Medulloblastoma/CNS PNET of Childhood, A COG Randomized Phase II Screening Trial Trial Opening Date ACNS0821 opened ...; Created on 24 April 2013
5. ACNS0334: Newly Diagnosed Supratentorial PNET and High Risk Medulloblastoma in Children: (Family Protocol Summaries ); ... High Risk Medulloblastoma in Children < 36 Months Old with Intensive Induction Chemotherapy with Methotrexate Followed by Consolidation with Stem Cell Rescue versus the Same Therapy without Methotrexate ...; Created on 12 January 2012
6. ACNS0332: A Phase III Study for Patients with High-risk Medulloblastoma and/or PNET: (Family Protocol Summaries ); ... is A Phase III study for patients with high risk Medulloblastoma and/or PNET Official Title:ACNS0332-Efficacy of Carboplatin Administered Concomitantly With Radiation and Isotretinoin as a Pro-Apoptotic ...; Created on 12 January 2012
7. ACNS0331: (Family Protocol Summaries ); ... Target Volume Boost Irradiation and Reduced Dose Craniospinal Radiotherapy (18 Gy) and Chemotherapy in Children with Newly Diagnosed Standard Risk Medulloblastoma: A Phase III Double Randomized Trial Trial ...; Created on 06 August 2013
8. Return of Results - FAQ: (Uncategorised); ... brain stem glioma, craniopharyngioma, medulloblastoma, and meningioma. Also called central nervous system tumor. DVL: Experimental Therapeutics (New Agents) In clinical trials, refers to a drug (including ...; Created on 11 February 2013
9. Phase 1: Publications: (Phase 1 Consortium); ... S. A phase I trial and pharmacokinetic (PK) study of vorinostat (SAHA) in combination with 13 cis-retinoic acid (13cRA) in children with refractory neuroblastomas, medulloblastomas, primitive neuroectodermal ...; Created on 13 June 2012
10. ACCL0431: A Randomized Phase III Study of Sodium Thiosulfate for the Prevention of Cisplatin-Induced Ototoxicity in Children: (Family Protocol Summaries ); ... will be treated with the chemotherapy medicine cisplatin. The most common childhood cancers that are treated with cisplatin include germ cell tumors, hepatoblastoma, medulloblastoma, neuroblastoma and ...; Created on 12 January 2012
11. ACCL0431: A Randomized Phase III Study of Sodium Thiosulfate for the Prevention of Cisplatin-Induced Ototoxicity in Children: (Family Protocol Summaries ); ... will be treated with the chemotherapy medicine cisplatin. The most common childhood cancers that are treated with cisplatin include germ cell tumors, hepatoblastoma, medulloblastoma, neuroblastoma and ...; Created on 11 January 2012
12. Recent Children's Cancer Researc: (Recent Children's Cancer Research ); ... children with neuroblastoma to determine how pieces of DNA associated with resistance to chemotherapy drugs in the laboratory setting compare to results in patient outcomes. Medulloblastoma Researchers ...; Created on 30 November 2011
13. Family Protocol Summaries: (Family Protocol Summaries ); ... with High-risk Medulloblastoma and/or PNET ACNS0831: A Phase 3 Randomized Trial of Post-Radiation Chemotherapy in Patients with Newly Diagnosed Ependymoma Ages 1 to 21 years ACNS1422: A Phase 2 Study ...; Created on 30 November 2011
14. In Treatment for Brain Tumors: (Types of Children's Cancer); ... have shown to be the most effective for that specific type of cancer. Below are some descriptions of the different types of brain tumors and their treatment protocols. Medulloblastoma Also called ...; Created on 03 October 2011
15. Newly Diagnosed with Brain Tumors: (Types of Children's Cancer); ... are more likely to develop a medulloblastoma, ependymoma or germ cell tumor than girls. Race and Ethnicity Caucasian children are more likely than African American children to develop a medulloblastoma ...; Created on 03 October 2011
16. Information for Research Collaborations: (Research Collaborations); ... common form of childhood cancer. COG conducts research in children with medulloblastoma, ependymoma, brainstem gliomas, low and high-grade gliomas, and germ cell tumors. The large multi-site structure ...; Created on 22 July 2011

The information and content provided on this website is made available for informational purposes only for children and their families affected by cancer. While the Children's Oncology Group strives to provide accurate and up-to-date information, the information may be out of date or incomplete in certain respects. Please do not rely on this information and seek the care of a qualified medical professional if you have questions regarding a specific medical condition, disease, diagnosis or symptom. The information and content presented herein is not intended to replace the independent clinical judgement, medical advice, screening, health counseling, or other intervention performed by your (or your child's) health care provider. Please contact "911" or your emergency services if this is a health emergency. No endorsement of any specific tests, products, or procedures is made herein.